b'36 Mercia asset Management PLc Annual Report and Accounts 2021Our portfolio continuedDiversified investmentthe native antigen company (nac)NAC was sold to LGC, a global leader in the Life Sciences Tools sector, for 18.0million generating an 8.4x return on investment cost and a 65% IRR for our direct holding.53.3mVCT and EIS liquidity'